Data / Research funding / Heart Disease - Coronary Heart Disease
Heart Disease - Coronary Heart Disease: 1,398 NIH awards ($1.8B) to 275 organizations
1,398 NIH awards ($1.8B) in the NIH spending category Heart Disease - Coronary Heart Disease, to 275 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,398 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| JACKSON HEART STUDY (JHS) FIELD CENTER (FC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $14,739,138 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,919,988 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.3 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,712,636 | November 15, 2024 | September 30, 2025 | COUPER, DAVID | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,079,314 | April 1, 2021 | March 31, 2027 | HOCHMAN, JUDITH S | reporter.nih.gov |
| Immune Cell Interactions in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,386,571 | August 1, 2017 | May 31, 2027 | HEDRICK, CATHERINE C | reporter.nih.gov |
| Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,752,600 | June 1, 2021 | May 31, 2026 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,671,281 | September 1, 2021 | May 31, 2027 | PINELLO, LUCA | reporter.nih.gov |
| REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,345,645 | September 10, 2022 | July 31, 2027 | SAFFORD, MONIKA M | reporter.nih.gov |
| Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,505,536 | September 1, 2021 | July 31, 2027 | DAUBERT, MELISSA | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,198,164 | August 15, 2022 | June 30, 2027 | LACROIX, ANDREA Z. | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $5,394,975 | September 30, 2015 | July 31, 2025 | MARK, DANIEL B | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) UNDERGRADUATE TRAINING AND EDUCATION CENTER (UTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,146,731 | August 13, 2023 | August 12, 2025 | WHITE, WENDY | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,086,390 | November 15, 2021 | March 14, 2026 | LUTSEY, PAMELA L. | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,994,412 | November 15, 2021 | February 19, 2026 | WAGENKNECHT, LYNNE E | reporter.nih.gov |
| IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,866,733 | July 1, 2022 | June 30, 2027 | ERICKSON, LOREN D | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,813,353 | January 15, 2025 | January 14, 2026 | WINDHAM, BEVERLY GWEN | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,714,816 | January 1, 2025 | December 31, 2025 | ARGANI, PEDRAM | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,701,181 | August 13, 2023 | August 12, 2025 | PAYTON, MARINELLE | reporter.nih.gov |
| Multi-functional anti-thrombotic therapy for coronary microvascular obstruction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,660,810 | May 1, 2023 | April 30, 2027 | CHEN, RIDONG | reporter.nih.gov |
| Altering Cardiac Cell Fate for Heart Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,621,749 | January 13, 2021 | November 30, 2027 | QIAN, LI | reporter.nih.gov |
| IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,621,686 | July 1, 1984 | May 31, 2028 | PLATTS-MILLS, THOMAS A. | reporter.nih.gov |
| PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,550,671 | February 15, 2023 | January 31, 2027 | ALBERT, CHRISTINE M | reporter.nih.gov |
| Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,444,163 | August 20, 2021 | July 31, 2027 | DEFILIPPIS, ANDREW | reporter.nih.gov |
| The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $4,414,294 | September 29, 2009 | December 31, 2026 | MANSON, JOANN ELISABETH | reporter.nih.gov |
| Mechanisms of Platelet Activity in Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,269,155 | February 15, 2019 | January 31, 2027 | BERGER, JEFFREY S | reporter.nih.gov |
| Cardiorenal Genomics for Risk Prediction in African Descent Populations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,261,183 | September 1, 2021 | August 31, 2028 | IRVIN, MARGUERITE R | reporter.nih.gov |
| Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,062,443 | January 1, 2019 | April 30, 2028 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Diagnosis, Prevention, And Treatment Of Cardiovascular Diseases With Genome Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,046,250 | March 20, 2019 | February 28, 2026 | MUSUNURU, KIRAN | reporter.nih.gov |
| Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,034,369 | June 1, 2022 | May 31, 2029 | SLOMKA, PIOTR J | reporter.nih.gov |
| Immune checkpoint inhibitors and accelerated coronary atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,014,114 | May 1, 2022 | April 30, 2027 | NEILAN, TOMAS G | reporter.nih.gov |
| Engineered Stem Cells for Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,984,462 | February 1, 2018 | March 31, 2027 | REGNIER, MICHAEL | reporter.nih.gov |
| RSK3 Anchoring Disruptor Therapy for Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $3,961,080 | September 14, 2023 | July 31, 2025 | CIVIDINI, FEDERICO | reporter.nih.gov |
| Cardiac lineage determination and nuclear architecture | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,927,168 | January 1, 2018 | December 31, 2024 | EPSTEIN, JONATHAN A. | reporter.nih.gov |
| Imaging organ system interfaces in ischemic heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,920,729 | February 1, 2018 | January 31, 2025 | NAHRENDORF, MATTHIAS | reporter.nih.gov |
| Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of AtheroSclerotic CardioVascular Disease (HIDDEN-ASCVD) Study | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,918,561 | September 27, 2025 | August 31, 2029 | AMBROSY, ANDREW PATRICK | reporter.nih.gov |
| 1/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,886,403 | July 30, 2025 | June 30, 2027 | PAGIDIPATI, NEHA JADEJA | reporter.nih.gov |
| Managing Cardiac Toxicities of Cancer Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,865,725 | January 1, 2021 | December 31, 2027 | SALLOUM, FADI N | reporter.nih.gov |
| Jackson Heart Study (JHS) Field Center | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,819,327 | September 15, 2025 | September 14, 2026 | reporter.nih.gov | |
| Catheter for Complex Percutaneous Coronary Intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,814,040 | July 20, 2020 | January 31, 2027 | FISCHELL, TIM ALEXANDER | reporter.nih.gov |
| Jackson Heart Study (JHS) Coordinating Center: Task Area A - Core Study Operations | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,791,131 | September 15, 2025 | September 14, 2035 | reporter.nih.gov | |
| Investigating Mechanisms for Lipid Transport in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,725,279 | July 1, 2018 | June 30, 2025 | YOUNG, STEPHEN G. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,682,352 | August 13, 2023 | August 12, 2025 | RENEKER, JENNIFER | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,595,504 | February 1, 2022 | June 30, 2026 | SHAW, LESLEE J | reporter.nih.gov |
| Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,593 | April 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| PP2A Anchoring Disruptor Therapy in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,544,947 | September 1, 2021 | August 31, 2025 | CIVIDINI, FEDERICO | reporter.nih.gov |
| Ultrasound Targeted Microbubble Cavitation to Treat Coronary Microvascular Obstruction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,534,234 | May 17, 2021 | April 30, 2027 | PACELLA, JOHN J | reporter.nih.gov |
| Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,475,737 | September 15, 2020 | August 31, 2025 | VAIDYA, ANAND | reporter.nih.gov |
| Leveraging zebrafish models to dissect and enhance heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,454,465 | May 15, 2020 | December 31, 2024 | POSS, KENNETH D | reporter.nih.gov |
| L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,437,123 | December 20, 2020 | December 31, 2028 | LOSCALZO, JOSEPH | reporter.nih.gov |
| Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | NIH | National Cancer Institute | 2021 to 2025 | $3,435,650 | April 1, 2022 | March 31, 2027 | MONTGOMERY, GUY H | reporter.nih.gov |
| Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,431,403 | September 10, 2021 | August 31, 2026 | MARCU, LAURA | reporter.nih.gov |
| New Approaches to Mitigate Left Ventricular Injury with VA-ECMO in Acute Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,429,326 | August 1, 2021 | July 31, 2025 | KAPUR, NAVIN KUMAR | reporter.nih.gov |
| Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,417,341 | January 15, 2022 | December 31, 2028 | LAVINE, KORY J. | reporter.nih.gov |
| SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM ("MIRTH" AND "SCIMITAR" DEVICES) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,399,623 | April 1, 2022 | March 31, 2026 | RAFIEE, NASSER | reporter.nih.gov |
| Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,398,319 | January 15, 2019 | December 31, 2024 | LEEPER, NICHOLAS JAMES | reporter.nih.gov |
| Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,332,837 | April 21, 2020 | March 31, 2026 | GAUDINO, MARIO FL | reporter.nih.gov |
| Molecular Regulation of Atherosclerosis Regression - Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,330,002 | April 1, 2006 | February 28, 2026 | FISHER, EDWARD A | reporter.nih.gov |
| Using genetic variation to study biology of blood lipids & coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,324,792 | April 1, 2015 | June 30, 2026 | PELOSO, GINA MARIE | reporter.nih.gov |
| Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,298,936 | July 1, 2022 | June 30, 2027 | LI, DEBIAO | reporter.nih.gov |
| Young Adult and Midlife Transitions in Physical Activity and Sedentary Behavior with Heart Failure Risk and Progression: Coronary Artery Risk Development in Young Adults (CARDIA) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,296,238 | August 1, 2020 | July 31, 2025 | GABRIEL, KELLEY PETTEE | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COMMUNITY ENGAGEMENT CENTER - TASK AREA B: DEMONSTRATION PROJECTS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,272,668 | September 25, 2023 | September 24, 2024 | SUTTON, VICTOR D | reporter.nih.gov |
| Vascular Dysfunction in Myocardial Ischemia and Metabolic Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,258,608 | April 1, 2016 | June 30, 2027 | SELLKE, FRANK W | reporter.nih.gov |
| Exercise Intolerance in Non Obstructive Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,213,836 | May 1, 2022 | February 28, 2027 | ABRAHAM, THEODORE P | reporter.nih.gov |
| Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,202,489 | July 1, 2021 | June 30, 2026 | WEI, JANET | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,193,873 | December 1, 2021 | November 30, 2026 | TSENG, ZIAN H | reporter.nih.gov |
| Early Developmental Risk for Adult Cardiovascular Disease: High risk Subgroups, Biomarkers, and Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,193,149 | August 1, 2024 | May 31, 2028 | BUKA, STEPHEN L | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Polygenic Risk of Disease in Populations of Diverse Ancestry | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,159,052 | September 8, 2021 | April 30, 2027 | SCHAID, DANIEL J. | reporter.nih.gov |
| Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,155,829 | January 1, 2022 | December 31, 2025 | OWENS, GARY K | reporter.nih.gov |
| L-type channel trafficking and modulation in heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,142,708 | August 1, 2014 | April 30, 2027 | COLECRAFT, HENRY M. | reporter.nih.gov |
| Molecular control of cardiac regenerative potential | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,142,578 | December 1, 2017 | December 31, 2026 | HUANG, GUO | reporter.nih.gov |
| Chemokines in healing myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,140,955 | June 6, 2005 | May 31, 2028 | FRANGOGIANNIS, NIKOLAOS G | reporter.nih.gov |
| Mechanisms of atherosclerotic cardiovascular complications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,538 | September 1, 2022 | August 31, 2026 | GIANNARELLI, CHIARA | reporter.nih.gov |
| The role of signaling adaptor protein epsin in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,138,613 | December 15, 2020 | November 30, 2025 | CHEN, HONG | reporter.nih.gov |
| High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,136,707 | July 1, 2022 | June 30, 2026 | SHERWOOD, RICHARD I | reporter.nih.gov |
| Mental Stress Reactivity in Women with Coronary Microvascular Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,125,714 | January 1, 2022 | April 29, 2025 | MEHTA, PUJA KIRAN | reporter.nih.gov |
| Molecular Imaging of Collagen Turnover in Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,124,954 | July 1, 2022 | June 30, 2027 | SADEGHI, MEHRAN M | reporter.nih.gov |
| Push-Button Cardiac MRI for Non-Invasive Quantification of Myocardial Energy Consumption in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,123,890 | August 15, 2022 | June 30, 2027 | YANG, HSIN-JUNG | reporter.nih.gov |
| Investigation of Sex and Gender Differences in Cardiovascular Risk in Rural Communities | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,116,310 | March 1, 2023 | February 29, 2028 | SHAH, AMIT JASVANT | reporter.nih.gov |
| Cardiovascular risk from comprehensive evaluation of the CT calcium score exam | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,104,134 | March 15, 2023 | February 28, 2027 | WILSON, DAVID LYNN | reporter.nih.gov |
| Regulation of Myocardial Phospholipases and Lipases in Diabetic Myocardium | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,101,106 | June 1, 2013 | January 31, 2026 | GROSS, RICHARD W | reporter.nih.gov |
| Aspirin-triggered Specialized Pro-resolving Mediators in Increasing Weight and Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,089,508 | April 1, 2021 | March 31, 2027 | HEFFRON, SEAN PATRICK | reporter.nih.gov |
| Resolution of inflammation in healing myocardial infarcts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,125 | January 15, 2008 | December 31, 2026 | FRANGOGIANNIS, NIKOLAOS G | reporter.nih.gov |
| Ferumoxytol-Enhanced Cardiac MRI for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,066,463 | July 1, 2020 | June 30, 2026 | NGUYEN, KIM-LIEN T | reporter.nih.gov |
| Apolipoprotein M: a novel regulator of myocardial Autophagy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,065,388 | September 1, 2021 | August 31, 2026 | JAVAHERI, ALI | reporter.nih.gov |
| Causal variant association mechanisms in TCF21 binding coronary disease loci | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,054,012 | January 1, 2017 | November 30, 2028 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| The PREVENTABLE Physical Performance Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $3,040,350 | September 30, 2021 | May 31, 2028 | HOUSTON, DENISE KATHRYN | reporter.nih.gov |
| The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,039,522 | December 1, 2021 | November 30, 2026 | CHEN, HONG | reporter.nih.gov |
| Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,038,586 | September 1, 1976 | May 5, 2026 | COLLER, BARRY | reporter.nih.gov |
| Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,020,183 | April 1, 2018 | March 31, 2025 | CHAUHAN, ANIL KUMAR | reporter.nih.gov |
| The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,015,015 | January 1, 2021 | December 31, 2025 | ZHAO, MING | reporter.nih.gov |
| The Identification and characterization of genetic variants underlying cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,015,000 | January 23, 2017 | December 31, 2023 | MANI, ARYA | reporter.nih.gov |
| Genome-wide association study of coronary artery disease in individuals of African ancestry | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,009,772 | August 1, 2021 | July 31, 2025 | LU, YINGCHANG | reporter.nih.gov |
| Whole-genome sequencing analysis of coronary atherosclerosis and related traits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,003,154 | March 17, 2020 | February 28, 2026 | DE VRIES, PAUL STEFAN | reporter.nih.gov |
| Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,993,449 | April 1, 2021 | March 31, 2026 | CHEN, HONG | reporter.nih.gov |
| Clinical translation of targeted intracoronary imaging for inflammatory activity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,992,135 | July 22, 2022 | June 30, 2027 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,986,551 | August 1, 2017 | August 31, 2027 | WINGER, JONATHAN A | reporter.nih.gov |
| Super Resolution Ultrasound Imaging of Vasa Vasorum to Characterize the Progression of Atherosclerotic Plaques and Predict Rupture Vulnerability | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,981,035 | February 1, 2022 | January 31, 2027 | KIM, KANG | reporter.nih.gov |
| Dietary Etiologies of Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,960,284 | December 1, 1985 | May 19, 2025 | RIMM, ERIC B | reporter.nih.gov |
| Multiparametric MRI for the investigation of coronary microvascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,958,179 | May 12, 2022 | April 30, 2027 | EPSTEIN, FREDERICK H | reporter.nih.gov |
| Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,945,022 | May 1, 2019 | July 31, 2028 | NATARAJAN, PRADEEP | reporter.nih.gov |
| Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors | NIH | National Cancer Institute | 2022 to 2025 | $2,933,453 | July 15, 2022 | April 30, 2027 | HOWELL, REBECCA MAUREEN | reporter.nih.gov |
| Increasing Ischemic Myocardial Tissue Perfusion by Mechanical LV Support | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,933,083 | December 15, 2017 | November 30, 2026 | ISHIKAWA, KIYOTAKE | reporter.nih.gov |
| Infusible Extracellular Matrix for Treating Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,929,153 | June 10, 2022 | May 31, 2027 | CHRISTMAN, KAREN L | reporter.nih.gov |
| 2/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,915,073 | May 1, 2023 | April 30, 2027 | LU, MICHAEL TSE-YIN | reporter.nih.gov |
| Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,900,593 | July 1, 2021 | June 30, 2025 | OWENS, GARY K | reporter.nih.gov |
| Mitochondrial ATP Synthase in Cardiac Biology and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,896,074 | June 1, 2022 | May 31, 2027 | KITSIS, RICHARD N | reporter.nih.gov |
| Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CT | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,885,687 | September 22, 2022 | June 30, 2027 | SLOMKA, PIOTR J | reporter.nih.gov |
| Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection | NIH | National Institute on Aging | 2021 to 2023 | $2,851,326 | May 1, 2019 | January 31, 2025 | TRIANT, VIRGINIA ATHENA | reporter.nih.gov |
| Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients with Coronary Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,842,930 | June 1, 2020 | May 31, 2025 | FREEDLAND, KENNETH E | reporter.nih.gov |
| Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,835,005 | February 10, 2020 | January 31, 2024 | GROSS, ROBERT | reporter.nih.gov |
| Deciphering the role of a circadian lncRNA in cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,822,221 | April 1, 2022 | March 31, 2027 | ZHANG, LILEI | reporter.nih.gov |
| Personalized Patient data and behavioral nudges to improve adherence to chronic cardiovascular medications | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,821,352 | July 1, 2018 | June 30, 2025 | ALLEN, LARRY ALEXANDER | reporter.nih.gov |
| Cell-Type Specific Mechanisms of HIV Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,817,007 | December 6, 2021 | November 30, 2025 | CHI, NEIL C | reporter.nih.gov |
| Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,816,253 | July 1, 2016 | November 30, 2026 | ZHANG, JIANYI | reporter.nih.gov |
| Mechanisms of vascular and valvular calcification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,799,000 | January 1, 2018 | December 31, 2023 | GIACHELLI, CECILIA M | reporter.nih.gov |
| AIBP therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,790,000 | February 1, 2017 | January 31, 2024 | MILLER, YURY | reporter.nih.gov |
| Precision antiplatelet therapy after percutaneous coronary intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,788,098 | July 15, 2020 | June 30, 2026 | CAVALLARI, LARISA HUMMA | reporter.nih.gov |
| Sympathetic remodeling and ventricular arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,772,140 | September 1, 2025 | June 30, 2029 | RIPPLINGER, CRYSTAL MAY | reporter.nih.gov |
| Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,768,708 | September 12, 2014 | June 30, 2027 | CRANE, HEIDI M. | reporter.nih.gov |
| Personalized lesion modification optimizes atherosclerosis intervention | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,767,637 | January 1, 2022 | December 31, 2025 | EDELMAN, ELAZER R | reporter.nih.gov |
| Role of GPNMB in cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,753,048 | December 20, 2020 | November 30, 2025 | DEB, ARJUN | reporter.nih.gov |
| New Risk Models for Diabetes Complications Using Electronic Health Records | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,749,048 | April 1, 2022 | March 31, 2027 | NAU, CLAUDIA LEONIE | reporter.nih.gov |
| Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,745,822 | July 1, 2021 | June 30, 2026 | SHI, JINJUN | reporter.nih.gov |
| THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,745,000 | January 16, 2017 | December 31, 2023 | DORN, GERALD W. | reporter.nih.gov |
| Protection of Ischemic Myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,741,275 | December 1, 2004 | August 31, 2023 | BOLLI, ROBERTO | reporter.nih.gov |
| Computational model-driven design to mitigate vein graft failure after coronary artery bypass | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,736,546 | August 15, 2022 | June 30, 2027 | MARSDEN, ALISON L | reporter.nih.gov |
| Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,730,969 | August 1, 2020 | May 31, 2026 | NAVAS-ACIEN, ANA | reporter.nih.gov |
| Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,730,095 | July 1, 2022 | June 30, 2026 | KASSAB, GHASSAN S | reporter.nih.gov |
| Role of group 2 innate lymphoid cells in myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,714,930 | December 15, 2021 | November 30, 2026 | LIBBY, PETER | reporter.nih.gov |
| Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,702,022 | April 1, 2020 | March 31, 2026 | O'CONNELL, TIMOTHY D | reporter.nih.gov |
| PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,687,815 | April 15, 2021 | March 31, 2026 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,686,324 | March 15, 2022 | February 28, 2027 | FIGUEROA, CARLOS ALBERTO | reporter.nih.gov |
| Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,675,195 | August 9, 2022 | June 30, 2027 | ZHU, WUQIANG | reporter.nih.gov |
| Multi-isotope Hybrid PET/CT Imaging of Peripheral Artery Disease in Diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,663,222 | December 19, 2022 | November 30, 2025 | SINUSAS, ALBERT J | reporter.nih.gov |
| Dissecting the role of CD8+ T cells in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,662,899 | August 20, 2020 | May 31, 2025 | GIANNARELLI, CHIARA | reporter.nih.gov |
| Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,657,964 | April 1, 2021 | March 31, 2026 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Multimodal genetic regulatory architecture of coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,653,823 | June 1, 2019 | June 30, 2028 | MILLER, CLINT L | reporter.nih.gov |
| Trans-omic Analysis of Alcohol Consumption and its Relation to Cardiovascular Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,649,589 | July 1, 2021 | April 30, 2027 | LIU, CHUNYU | reporter.nih.gov |
| ShRNA-Based Targeting of mAKAPβ in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,647,016 | July 1, 2019 | April 30, 2024 | CIVIDINI, FEDERICO | reporter.nih.gov |
| Ventricular arrhythmias and mechanisms of parasympathetic dysfunction following myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,637,195 | July 1, 2020 | June 30, 2025 | VASEGHI, MARMAR | reporter.nih.gov |
| Slowing Atherothrombosis Progression through Indoor Air Filtration: A Crossover Trial in Hispanic and non-Hispanic Adults with Ischemic Heart Disease History | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $2,604,505 | September 1, 2022 | June 30, 2027 | CHEN, ZHANGHUA | reporter.nih.gov |
| Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,587,786 | July 1, 2020 | June 30, 2025 | NEZAFAT, REZA | reporter.nih.gov |
| Modulation of Mitofusin Activity to Treat Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,574,028 | August 1, 2021 | July 31, 2025 | KITSIS, RICHARD N | reporter.nih.gov |
| Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,572,517 | April 1, 2022 | March 31, 2027 | BOWLES, DOUGLAS K | reporter.nih.gov |
| Improve the Meaning of Patient Reported Outcomes to Evaluate Effectiveness for Cardiac Care" (IMPROVE-Cardiac Care) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,557,678 | July 23, 2022 | June 30, 2027 | MASTERSON CREBER, RUTH MARIE | reporter.nih.gov |
| Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,552,315 | April 1, 2021 | March 31, 2026 | ZUCKER, IRVING H | reporter.nih.gov |
| Impact of cardiomyocyte cell cycle activity on atrial structural and functional remodeling following myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,552,004 | April 22, 2022 | March 31, 2027 | FIELD, LOREN J | reporter.nih.gov |
| YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,549,340 | December 15, 2021 | November 30, 2026 | LIN, ZHIQIANG | reporter.nih.gov |
| Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,547,645 | July 1, 2020 | April 30, 2026 | MOGHTADERI, ALI | reporter.nih.gov |
| Functional roles of lymphatics in organogenesis and tissue repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,543,362 | January 7, 2021 | December 31, 2025 | OLIVER, GUILLERMO C | reporter.nih.gov |
| Genetic interactions and multifactorial genetics mediate myocardial regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,532,602 | February 11, 2021 | June 30, 2026 | PATTERSON, MICHAELA | reporter.nih.gov |
| Cyclic nucleotide phosphodiesterase regulation in vascular calcification | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,529,665 | June 15, 2022 | May 31, 2027 | CAI, YUJUN | reporter.nih.gov |
| Vascular dysfunction in coronary microcirculation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,526,989 | December 10, 2021 | November 30, 2026 | DAS, KUMUDA C | reporter.nih.gov |
| Dual Functionality of Ceramide in Human Microvascular Endothelial Function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,525,399 | July 1, 2022 | June 30, 2027 | FREED, JULIE K | reporter.nih.gov |
| CARDIA-PLUS: A Life Course Investigation of Biopsychosocial Pathways to Bladder Health and Lower Urinary Tract Symptoms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,525,060 | August 15, 2021 | July 31, 2025 | BRADY, SONYA S | reporter.nih.gov |
| Integrating Coronary Atherosclerosis with Physiologic Features for Optimized Risk Stratification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,517,408 | March 4, 2021 | February 28, 2026 | STONE, PETER HOWARD | reporter.nih.gov |
| IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - COORDINATING CENTER - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,517,180 | November 15, 2016 | November 14, 2021 | COUPER, DAVID | reporter.nih.gov |
| CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,516,934 | January 15, 2020 | December 31, 2025 | CHEN, HONG | reporter.nih.gov |
| PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,514,537 | August 1, 2020 | May 19, 2025 | GAZIANO, THOMAS A | reporter.nih.gov |
| Intravascular microstructural, chemical and biomechanical characterization of coronary plaques | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,503,838 | August 1, 2022 | April 30, 2027 | URIBE-PATARROYO, NESTOR | reporter.nih.gov |
| A hypercholesterolemia-induced immunometabolite in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,499,404 | December 1, 2021 | November 30, 2025 | SHAH, PREDIMAN KRISHAN | reporter.nih.gov |
| Prevention of heart failure with IL-1 blockade: a mechanistic study | NIH | National Institute on Aging | 2022 to 2025 | $2,490,717 | March 1, 2022 | February 28, 2027 | VAN TASSELL, BENJAMIN W | reporter.nih.gov |
| Mechanisms of Gap Junction Regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,488,213 | June 1, 2006 | June 30, 2027 | SORGEN, PAUL L | reporter.nih.gov |
| Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,488,056 | April 1, 2023 | March 31, 2027 | COKIC, IVAN | reporter.nih.gov |
| 3D Multi-Functional Catheter-Based Imaging of Coronary Lesion Composition, Structure, and Hemodynamics in Intermediate Stenoses | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,487,260 | July 1, 2021 | March 31, 2026 | LINDSEY, BROOKS D | reporter.nih.gov |
| New methods for constructing and evaluating polygenic scores | NIH | National Human Genome Research Institute | 2021 to 2023 | $2,484,299 | September 14, 2020 | June 30, 2025 | PRITCHARD, JONATHAN K | reporter.nih.gov |
| Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,484,226 | July 1, 2023 | June 30, 2028 | FAHED, AKL C | reporter.nih.gov |
| Mechanobiology of Cardiopulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,483,485 | January 11, 2017 | December 31, 2023 | MERRYMAN, WILLIAM D | reporter.nih.gov |
| Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,475,519 | July 15, 2022 | June 30, 2027 | KITSIS, RICHARD N | reporter.nih.gov |
| Neurotrophins and post-infarct plasticity in cardiac sympathetic neurons | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,471,774 | July 15, 2009 | June 30, 2028 | HABECKER, BETH A | reporter.nih.gov |
| Cell-Selective Therapies for Coronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,469,740 | July 15, 2015 | December 31, 2026 | TOTARY-JAIN, HANA | reporter.nih.gov |
| PIK3C3, a master regulator for smooth muscle identity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,467,369 | December 1, 2021 | November 30, 2026 | ZHOU, JILIANG | reporter.nih.gov |
| Engineered Granular Hydrogels for Endogenous Tissue Repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,464,894 | May 26, 2022 | April 30, 2027 | BURDICK, JASON A | reporter.nih.gov |
| Mechanism of transplanted neonatal cardiac progenitor cells to repair ischemic myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,462,741 | April 20, 2014 | August 31, 2025 | SCHUMACKER, PAUL T | reporter.nih.gov |
| ETS2-dependent control in cardiomyocyte ischemia/reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,459,070 | August 1, 2022 | July 31, 2026 | HILL, JOSEPH A | reporter.nih.gov |
| Genetic modifiers of atherosclerosis and macrophage phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,457,383 | July 1, 2021 | June 30, 2026 | SMITH, JONATHAN D | reporter.nih.gov |
| Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,454,092 | May 15, 2021 | April 30, 2027 | NIKPAY, SAYEH SANDER | reporter.nih.gov |
| Sex-Specific Risk of Metabolic and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,450,619 | June 15, 2019 | June 30, 2025 | STAFFORD, JOHN MICHAEL | reporter.nih.gov |
| Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,447,412 | December 15, 2017 | December 31, 2027 | JENSEN, BRIAN C | reporter.nih.gov |
| A novel psychological-behavioral intervention to promote physical activity after acute coronary syndrome | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,439,296 | June 1, 2022 | June 30, 2027 | HUFFMAN, JEFF C | reporter.nih.gov |
| Translating post-infarct ventricular tachycardia mechanisms into a therapy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,437,249 | January 9, 2023 | December 31, 2026 | DONAHUE, J KEVIN | reporter.nih.gov |
| Gut microbial metabolites and risk of coronary heart disease: a prospective, multiethnic, metabolomic study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,429,547 | July 15, 2020 | June 30, 2025 | YU, DANXIA | reporter.nih.gov |
| Dissecting the role of the cardiac fibroblast in hypertrophy. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,423,816 | July 18, 2022 | April 30, 2026 | MOLKENTIN, JEFFERY D | reporter.nih.gov |
| miR-181b, endothelial cells, and vascular inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,414,330 | August 1, 2012 | July 31, 2026 | FEINBERG, MARK W | reporter.nih.gov |
| Genetic circuitry governing heart growth and repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,413,285 | March 1, 2022 | February 28, 2027 | HUANG, GUO | reporter.nih.gov |
| Innate immune response signaling in cardiac injury healing | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,408,533 | January 1, 2022 | December 31, 2026 | MOLKENTIN, JEFFERY D | reporter.nih.gov |
| Development of advanced cardiac SPECT imaging technologies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,404,971 | August 1, 2020 | June 30, 2025 | LIU, CHI | reporter.nih.gov |
| Ultra-processed Foods, Diet Quality, and Cardiometabolic Health: An Inter-disciplinary Trans-Atlantic Collaborative Project | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,403,242 | April 15, 2019 | June 30, 2030 | SUN, QI | reporter.nih.gov |
| Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,401,494 | April 15, 2023 | March 31, 2027 | OWENS, GARY K | reporter.nih.gov |
| Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,398,270 | December 1, 2021 | November 30, 2026 | HUI, DAVID YIU-KWAN | reporter.nih.gov |
| SPHINGOLIPID BIOLOGY OF MACROPHAGE IN CORONARY ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,395,181 | January 1, 2021 | December 31, 2025 | DI LORENZO, ANNARITA | reporter.nih.gov |
| Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,389,719 | May 1, 2019 | February 28, 2026 | BAIREY MERZ, CATHLEEN NOEL | reporter.nih.gov |
| Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,389,239 | July 15, 2023 | June 30, 2027 | OWENS, GARY K | reporter.nih.gov |
| Electrocardiographic Detection of Non-ST Elevation Myocardial Events for Accelerated Classification of Chest Pain Encounters (ECG-SMART 2) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,387,374 | April 15, 2018 | June 30, 2026 | AL-ZAITI, SALAH S | reporter.nih.gov |
| Endothelial plasticity in cardiac repair after myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,384,851 | August 11, 2021 | July 31, 2025 | FAN, YI | reporter.nih.gov |
| CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,382,655 | April 1, 2021 | March 31, 2026 | WANG, YIGANG | reporter.nih.gov |
| Very early drivers of neutrophilic inflammation in cardiac ischemia-reperfusion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,367,912 | August 1, 2018 | March 31, 2029 | LEVIT, REBECCA DIANE | reporter.nih.gov |
| Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,366,065 | September 1, 2022 | August 31, 2026 | KHEIR, JOHN NAGI | reporter.nih.gov |
| Mechanotransduction and transcriptional regulation during artery development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,363,601 | September 1, 2015 | June 30, 2025 | RED-HORSE, MARY | reporter.nih.gov |
| Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,361,031 | April 15, 2023 | March 31, 2027 | KIM, DANIEL | reporter.nih.gov |
| Molecular mechanisms of vascular calcification and their connection to coronary disease risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,360,671 | August 1, 2022 | May 31, 2027 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Blood mitochondrial DNA biomarkers of midlife cognitive decline and adverse brain imaging changes - A longitudinal investigation in the CARDIA population‐based cohort study | NIH | National Institute on Aging | 2021 to 2023 | $2,348,964 | July 15, 2020 | April 30, 2025 | BACCARELLI, ANDREA | reporter.nih.gov |
| Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,346,100 | July 1, 2023 | April 30, 2027 | KIM, DOKYOON | reporter.nih.gov |
| Evaluation of artificial intelligence-controlled CPR to improve vital organ perfusion and survival during prolonged resuscitation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,342,113 | April 15, 2021 | March 31, 2026 | YANNOPOULOS, DEMETRIS | reporter.nih.gov |
| Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,339,875 | August 1, 2020 | June 30, 2025 | FEINSTEIN, MATTHEW JOEL | reporter.nih.gov |
| Cardioprotective role of Humanin in aging | NIH | National Institute on Aging | 2021 to 2025 | $2,334,715 | September 30, 2021 | May 31, 2027 | MUZUMDAR, RADHIKA HIREN | reporter.nih.gov |
| Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,334,070 | April 1, 2014 | January 31, 2025 | THORP, EDWARD BENJAMIN | reporter.nih.gov |
| Junctophilin-2 cleavage in ischemic heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,333,916 | April 1, 2021 | March 31, 2026 | WEHRENS, XANDER H.T. | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,327,515 | April 1, 2023 | March 31, 2027 | ZHANG, HANRUI | reporter.nih.gov |
| Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,324,312 | May 1, 2012 | July 31, 2025 | VACCARINO, VIOLA | reporter.nih.gov |
| Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,320,705 | September 1, 2023 | August 31, 2026 | LERNER, DANIEL J | reporter.nih.gov |
| Optimization of diagnostic accuracy, radiation dose, and patient throughput for cardiac SPECT via advanced and clinically practical cardiac-respiratory motion correction and deep learning | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,320,020 | July 1, 2020 | June 30, 2025 | YANG, YONGYI | reporter.nih.gov |
| Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CT | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,315,094 | February 15, 2023 | January 31, 2027 | WILSON, DAVID LYNN | reporter.nih.gov |
| Sociocultural Shifting, Sleep and Cardiometabolic Risk in African-American Women | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,314,054 | August 8, 2023 | July 31, 2028 | LEWIS, TENÉ T | reporter.nih.gov |
| Engineering a Microphysiological System to Model the Infarct Border Zone and Interrogate Oxygen-Dependent Cell-Cell Communication in the Myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,307,632 | June 15, 2020 | June 30, 2029 | MCCAIN, MEGAN LAURA | reporter.nih.gov |
| Mechanisms Underlying Takotsubo Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,301,876 | July 1, 2022 | December 31, 2026 | CHILIAN, WILLIAM M | reporter.nih.gov |
| Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,301,317 | July 5, 2017 | November 30, 2026 | MILLER, LAURENCE J | reporter.nih.gov |
| Functional genomics investigation of pleiotropic vascular disease loci | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,287,605 | June 15, 2022 | May 31, 2027 | MILLER, CLINT L | reporter.nih.gov |
| Flow regulation of the Alk1/Eng pathway in vascular homeostasis and disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,277,780 | July 15, 2023 | May 31, 2027 | EICHMANN, ANNE CHRISTINE | reporter.nih.gov |
| Elucidation of P2X7 Receptor Signaling and Development of Novel Small Molecule and Aptamer Ligand Therapies | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,276,100 | September 1, 2022 | August 31, 2027 | MANSOOR, STEVEN ELIAS | reporter.nih.gov |
| Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,275,582 | May 15, 2020 | March 31, 2025 | DEY, DAMINI | reporter.nih.gov |
| Coronary Atherosclerosis and Immune Activation in HIV and Tuberculosis Infection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,274,138 | August 2, 2022 | July 31, 2027 | HUAMAN JOO, MOISES ARTURO | reporter.nih.gov |
| A dual-layer flat panel x-ray detector based on an engineered amorphous chalcogenide alloy for quantifying coronary artery calcium | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,262,800 | September 7, 2022 | May 31, 2027 | ABBASZADEH, SHIVA | reporter.nih.gov |
| Cardiac Magnetic Resonance Tissue Characterization of Ischemic and Non-Ischemic Myocardium to Predict Left Ventricular Functional Recovery and Outcomes after Multivessel Coronary Revascularization | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,261,618 | September 1, 2023 | August 31, 2028 | GAUDINO, MARIO FL | reporter.nih.gov |
| Heterogeneity and predictors of stress reactivity in takotsubo syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,255,920 | March 1, 2020 | February 28, 2026 | SALMOIRAGO-BLOTCHER, ELENA | reporter.nih.gov |
| Phase resolved ARF optical coherence elastography for intravascular imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,255,269 | August 15, 2014 | June 30, 2026 | CHEN, ZHONGPING | reporter.nih.gov |
| Harnessing Platelet-Endothelial Interactions for Exosome Delivery | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,253,989 | April 1, 2019 | July 31, 2027 | CHENG, KE | reporter.nih.gov |
| Non-invasive imaging of reactive oxygen species in reperfusion injury myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,248,106 | July 1, 2023 | April 30, 2027 | WITSCHEY, WALTER R.T. | reporter.nih.gov |
| Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,248,079 | August 15, 2023 | May 31, 2028 | NEWMAN, JONATHAN D | reporter.nih.gov |
| Leveraging Hispanic/Latino diversity to map and characterize cardiovascular disease loci | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,242,384 | January 16, 2023 | December 31, 2026 | GRAFF, MARIAELISA | reporter.nih.gov |
| Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,239,092 | August 14, 2023 | June 30, 2027 | DEB, ARJUN | reporter.nih.gov |
| Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,238,763 | August 23, 2021 | July 31, 2026 | GLIDE-HURST, CARRI KAYE | reporter.nih.gov |
| Proteomic discovery in an inception cohort of acute myocardial infarction survivors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,226,608 | August 15, 2020 | July 31, 2025 | FLOYD, JAMES S | reporter.nih.gov |
| Scar Detection and Treatment with Droplet Activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,222,376 | April 1, 2020 | March 31, 2025 | PORTER, THOMAS R | reporter.nih.gov |
| Coronary Artery Calcium, Aortic Calcification and Density in MESA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,221,188 | April 1, 2020 | March 31, 2025 | BUDOFF, MATTHEW J | reporter.nih.gov |
| Extreme Heat and Acute Myocardial Infarction: Effect Modifications by Sex, Medical History, and Air Pollution | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,213,010 | September 4, 2023 | June 30, 2028 | CHEN, KAI | reporter.nih.gov |
| Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,200,489 | January 1, 2021 | December 31, 2025 | DEMER, LINDA L. | reporter.nih.gov |
| Improving Cardiac Rehabilitation outcomes through mobile case management (iCARE) | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,199,791 | September 14, 2020 | July 31, 2025 | OLSON, THOMAS PATRICK | reporter.nih.gov |
| The role of MLKL in the regulation of vascular calcification in CKD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,198,457 | June 1, 2016 | May 31, 2027 | MIYAZAKI, MAKOTO | reporter.nih.gov |
| Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,196,794 | January 1, 2023 | November 30, 2026 | ZHU, WUQIANG | reporter.nih.gov |
| Quantitative coronary flow capacity with low-dose CT for ischemia but no obstructive coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,195,209 | July 1, 2023 | April 30, 2028 | MOLLOI, SABEE | reporter.nih.gov |
| Sodium Dependent Inactivation of the Na+-Ca2+ exchange: Relevance to Cardiac Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,187,514 | December 18, 2020 | November 30, 2025 | OTTOLIA, MICHELA | reporter.nih.gov |
| Deviceless and Autonomous Prospective Cardiac CT Triggering | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,187,003 | August 1, 2020 | May 30, 2024 | DE MAN, BRUNO | reporter.nih.gov |
| Role of Cilp1 in Post-Natal Heart Response to Injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,184,041 | June 1, 2022 | May 31, 2027 | LIU, ZHI-PING | reporter.nih.gov |
| Mitochondrial metabolism and macrophage function post MI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,177,813 | July 1, 2020 | December 31, 2025 | TIAN, RONG | reporter.nih.gov |
| Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,177,784 | September 12, 2025 | June 30, 2029 | AHN, JIYOUNG | reporter.nih.gov |
| Premature aging disorders, metabolites, and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,173,716 | December 15, 2022 | November 30, 2026 | ABE, JUN-ICHI | reporter.nih.gov |
| Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,173,015 | April 1, 2022 | February 28, 2027 | STITZIEL, NATHAN OLIVER | reporter.nih.gov |
| Understanding the molecular mechanism of cardiomyocyte dedifferentiation and proliferation during regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,169,578 | January 1, 2022 | December 31, 2026 | TSANG, MICHAEL WAIKOK | reporter.nih.gov |
| Protein Kinase Novel 2 (PKN2) in heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,167,993 | January 1, 2021 | December 31, 2024 | CHEN, JU | reporter.nih.gov |
| Subendothelial Exosomes in Coronary Microvascular Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,167,298 | March 15, 2004 | March 31, 2026 | LI, PINLAN | reporter.nih.gov |
| Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,160,217 | April 22, 2020 | May 31, 2029 | MOHAMED, TAMER M A | reporter.nih.gov |
| Macrophages in homeostasis and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,158,562 | June 25, 2021 | February 28, 2024 | SWIRSKI, FILIP K | reporter.nih.gov |
| Extracellular Matrix Dynamics During Remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,156,647 | April 1, 2022 | March 31, 2027 | JONES, STEVEN P | reporter.nih.gov |
| Informing best practices for evaluation and treatment of myocardial injury during sepsis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,156,394 | September 1, 2023 | June 30, 2027 | WALKEY, ALLAN J. | reporter.nih.gov |
| Endothelial Regulation of Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,152,920 | January 1, 2022 | August 31, 2026 | BOSTROM, KRISTINA I | reporter.nih.gov |
| Mechanisms of epicardium-directed coronary vessel patterning | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,152,475 | September 1, 2022 | August 31, 2026 | SMALL, ERIC M | reporter.nih.gov |
| Retinoid Metabolism in the Adult Heart and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,140,517 | April 1, 2023 | March 31, 2027 | FOSTER, D BRIAN | reporter.nih.gov |
| Effects of chronic marijuana use on endothelial function | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,140,358 | July 1, 2023 | April 30, 2028 | SPRINGER, MATTHEW LAWRENCE | reporter.nih.gov |
| Ultrasound-mediated Controlled Hypoxemic Reperfusion for Inhibition of Reperfusion Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,138,796 | July 1, 2019 | April 30, 2025 | HAWORTH, KEVIN JOSEPH | reporter.nih.gov |
| Critical role of Mitochondrial Fission/Fusion in Regulation of Microvascular Endothelial Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,127,892 | August 1, 2021 | July 31, 2025 | BEYER, ANDREAS M | reporter.nih.gov |
| TRP channels in the regulation of vascular tone | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,126,388 | February 4, 2011 | June 30, 2026 | ZHANG, DAVID X. | reporter.nih.gov |
| Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,120,983 | April 1, 2021 | July 31, 2023 | KOCH, WALTER J. | reporter.nih.gov |
| Mechanisms controlling epicardial-dependent promotion of heart regeneration in zebrafish. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,118,750 | July 5, 2021 | June 30, 2027 | CAO, JINGLI | reporter.nih.gov |
| Human CDX2 Cells and Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,116,925 | July 21, 2020 | May 31, 2025 | CHAUDHRY, HINA W | reporter.nih.gov |
| Molecular and Cellular Regulation of Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,114,102 | January 4, 2024 | December 31, 2030 | GIACHELLI, CECILIA M | reporter.nih.gov |
| Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,113,979 | September 15, 2021 | August 31, 2025 | BAKER, JASON V | reporter.nih.gov |
| Genomic and Proteomic Architecture of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,113,515 | July 18, 2012 | January 31, 2024 | HERRINGTON, DAVID MCLEOD | reporter.nih.gov |
| Influence of sleep on the hematopoietic niche and atherosclerosis during aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,113,125 | July 1, 2021 | May 31, 2026 | MCALPINE, CAMERON STUART | reporter.nih.gov |
| Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,105,761 | September 1, 2021 | July 31, 2025 | SHUFELT, CHRISANDRA LEE | reporter.nih.gov |
| Mechanisms of Cardiac TRPV1 Afferent Remodeling in Ventricular Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,101,388 | September 15, 2021 | July 31, 2025 | AJIJOLA, OLUJIMI A | reporter.nih.gov |
| Mediterranean diet, Metabolites, and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,096,138 | July 15, 2013 | February 28, 2027 | HU, FRANK B | reporter.nih.gov |
| Proof of concept and dose response of CAM-6019 for HFrEF patients | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,095,748 | October 1, 2025 | September 30, 2027 | UMANSKY, KFIR | reporter.nih.gov |
| Calcineurin compartmentation and regulation of pathological cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,095,434 | April 1, 2021 | September 30, 2025 | KAPILOFF, MICHAEL SETH | reporter.nih.gov |
| Cell Based Immunomodulation to Promote Post-Infarct Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,094,218 | December 10, 2022 | November 30, 2027 | GHANTA, RAVI K | reporter.nih.gov |
| Extracellular miRNAs, innate immunity, and critical illness | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,091,584 | May 1, 2021 | February 28, 2027 | CHAO, WEI | reporter.nih.gov |
| Trial to Assess Chelation Therapy 2- TACT2 CCC | NIH | National Center for Complementary & Integrative Health | 2021 | $2,069,251 | September 30, 2015 | April 30, 2022 | LAMAS, GERVASIO A | reporter.nih.gov |
| Sorbs2 targeting and BK channel regulation in the coronary artery of patients with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,065,272 | August 5, 2022 | January 31, 2027 | LU, TONG | reporter.nih.gov |
| Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,062,719 | January 15, 2022 | December 31, 2026 | GAO, LIE | reporter.nih.gov |
| Manganese-based Contrast Agent for Cardiovascular MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,057,361 | December 15, 2020 | May 31, 2026 | HOFFMAN, VERA | reporter.nih.gov |
| Epigenetic mechanisms linking psychosocial stress with coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,054,791 | April 1, 2022 | March 31, 2027 | ZANNAS, ANTHONY S. | reporter.nih.gov |
| Inhibition of Radiation-Induced Coronary Microvascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,050,609 | January 15, 2021 | December 31, 2026 | POKHAREL, SARASWATI | reporter.nih.gov |
| Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,045,222 | September 18, 2024 | June 30, 2027 | FEINBERG, MARK W | reporter.nih.gov |
| Validation of Platelet Expression of FcɣRIIa as a Precision Tool | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,045,163 | August 11, 2022 | July 31, 2025 | OHRNBERGER, JEANNE | reporter.nih.gov |
| Insulin-Like Growth Factor-1 and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,035,860 | December 5, 2002 | June 30, 2027 | DELAFONTAINE, PATRICE | reporter.nih.gov |
| Cardiac MRI for Reperfusion Spatial Mapping to Improve Heart Failure Outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,024,459 | July 1, 2023 | April 30, 2028 | NGUYEN, KIM-LIEN T | reporter.nih.gov |
| A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,021,907 | December 15, 2019 | November 30, 2024 | ROSENFELD, MICHAEL G | reporter.nih.gov |
| Universal optical coherence polarimetry | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,020,013 | July 15, 2022 | April 30, 2026 | VILLIGER, MARTIN | reporter.nih.gov |
| Scarring and Arrhythmia in Infarcted Aged Hearts: Role of Senescent Fibroblasts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,019,793 | January 20, 2019 | December 31, 2022 | KOREN, GIDEON | reporter.nih.gov |
| Establishing a Useful and Usable "Out of the Box" Quality Improvement Library for Enhanced Health System Efficiency and Outcomes | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $2,016,276 | August 16, 2024 | May 31, 2026 | TOBIAS, MARC | reporter.nih.gov |
| Cardiovascular effects of oral bicarbonate in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,014,849 | August 24, 2022 | July 31, 2027 | RAPHAEL, KALANI LUKELA | reporter.nih.gov |
| Cytoskeletal Control of Yap in Heart Regeneration | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,013,365 | July 1, 2023 | June 30, 2027 | MARTIN, JAMES F | reporter.nih.gov |
| Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,012,689 | August 25, 2023 | July 31, 2028 | EGBE, ALEXANDER | reporter.nih.gov |
| Comprehensive CT Guided Coronary Artery Bypass Graft Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,010,927 | February 15, 2019 | January 31, 2026 | NIEMAN, KOEN | reporter.nih.gov |
| High-throughput cellular genetics to connect noncoding variants to coronary artery disease genes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,007,839 | April 1, 2023 | March 31, 2027 | GUPTA, RAJAT M | reporter.nih.gov |
| Sequence Variants Impacting Cardiomyocyte S-phase Activity in Inbred Mice Following Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,007,341 | February 15, 2021 | January 31, 2026 | FIELD, LOREN J | reporter.nih.gov |
| Troponin I phosphorylation as a novel novel cardiac inotrope | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,003,047 | April 1, 2023 | March 31, 2027 | BIESIADECKI, BRANDON J | reporter.nih.gov |
| Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,002,186 | September 18, 2024 | June 30, 2027 | MAJITHIA, AMIT | reporter.nih.gov |
| Cardiac Exosomes in myocardial Ischemic injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,000,368 | April 3, 2020 | November 30, 2023 | MUEHLSCHLEGEL, JOCHEN DANIEL | reporter.nih.gov |
| Biomedical 600 MHz High Field MR Spectroscopy and Imaging Magnet Upgrade | NIH | Office of the Director, National Institutes of Health | 2025 | $2,000,000 | May 1, 2025 | April 30, 2027 | ACKERMAN, JEROME L | reporter.nih.gov |
| SBIR TOPIC 111, PHASE II: A COMPACT PORTABLE MEDICAL OXYGEN GENERATOR | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,000,000 | September 30, 2025 | September 29, 2027 | ALFORD, JOHN M | reporter.nih.gov |
| Developing a new drug for treating myocardial ischemia/reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,998,610 | September 20, 2021 | August 31, 2025 | SKIDGEL, RANDAL A | reporter.nih.gov |
| A Role of PKG1a and Inhibitors of cGMP Phosphodiesterase in Post MI VT in Mouse Models for Type II Diabetes and Metabolic Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,996,226 | July 1, 2020 | June 30, 2024 | GALPER, JONAS BERNARD | reporter.nih.gov |
| The Role of Arylsulfatase in Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,995,798 | April 1, 2023 | March 31, 2027 | MALHOTRA, RAJEEV | reporter.nih.gov |
| Examining Susceptibility and Resistance Phenotypes to Enhance Understanding of the Genetic Basis of Major Coronary Artery Disease in Type 1 Diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,995,149 | July 27, 2022 | June 30, 2027 | MILLER, RACHEL GRACE | reporter.nih.gov |
| Cardiac CT Deblooming | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,994,352 | September 1, 2020 | March 15, 2024 | DE MAN, BRUNO | reporter.nih.gov |
| Pivotal Preclinical Studies of Novel Infusible ECM for Treating Acute MI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,992,340 | September 15, 2023 | July 31, 2026 | KINSEY, ADAM M | reporter.nih.gov |
| Change of Institution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,991,250 | January 1, 2017 | June 30, 2024 | BURNS, CAROLINE E | reporter.nih.gov |
| PAcific Islander, Native Hawaiian and Asian American Cardiovascular Health Epidemiology (PANACHE) Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,989,441 | August 4, 2023 | June 30, 2028 | GO, ALAN S | reporter.nih.gov |
| Comprehensive characterization of coronary atherosclerotic disease using photon-counting-detector dual-source CT and its impact on patient management | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,988,559 | May 1, 2020 | July 31, 2025 | MCCOLLOUGH, CYNTHIA H | reporter.nih.gov |
| Validation of Myocardial Oxygen Extraction Fraction Measurement with MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,985,848 | August 15, 2023 | June 30, 2027 | ZHENG, JIE | reporter.nih.gov |
| Developing Long Noncoding RNA Therapy for Precision Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,982,431 | April 1, 2019 | August 31, 2027 | CHENG, KE | reporter.nih.gov |
| Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,981,673 | August 10, 2023 | June 30, 2027 | REILLY, MUREDACH P | reporter.nih.gov |
| Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,981,608 | January 1, 2023 | December 31, 2026 | GUO, ZHENHENG | reporter.nih.gov |
| Fibroblast targeting for myocardial repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,977,819 | April 1, 2023 | March 31, 2027 | SPINALE, FRANCIS G | reporter.nih.gov |
| Reading workstation for clinical contrast echocardiography | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,975,527 | March 1, 2021 | August 31, 2025 | SKLENAR, JIRI | reporter.nih.gov |
| Computational and functional strategies to decipher lncRNAs in human atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,972,315 | February 1, 2020 | January 31, 2025 | REILLY, MUREDACH P | reporter.nih.gov |
| Cardioprotective mechanisms of novel noncoding RNA in myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,970,843 | April 1, 2023 | March 31, 2027 | MARBAN, EDUARDO | reporter.nih.gov |
| System-independent quantitative cardiac CT perfusion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,968,096 | August 1, 2021 | July 31, 2025 | ROY, DEBASHISH | reporter.nih.gov |
| Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,965,752 | May 26, 2020 | April 30, 2026 | AKCAKAYA, MEHMET | reporter.nih.gov |
| Deciphering Myofilament Modifications in Ischemic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,963,460 | March 1, 2013 | June 30, 2025 | GE, YING | reporter.nih.gov |
| Stress, inflammation and coronary endothelial injury in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,961,087 | September 2, 2022 | June 30, 2027 | HAYS, ALLISON G | reporter.nih.gov |
| Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,957,180 | August 1, 2023 | July 31, 2027 | TANG, PAUL | reporter.nih.gov |
| The role of Sertad4 in pathologic cardiac remodeling. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,954,389 | July 1, 2022 | June 30, 2027 | STRATTON, MATTHEW | reporter.nih.gov |
| Switch of Osteogenesis in Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,950,000 | July 1, 2018 | June 30, 2026 | YAO, YUCHENG | reporter.nih.gov |
| Sensing and Clearance of Damaged Lysosomes in Macrophages and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,949,485 | November 4, 2014 | June 30, 2026 | RAZANI, BABAK | reporter.nih.gov |
| Deep probabilistic predictive models for stroke and coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,947,508 | September 1, 2019 | June 30, 2025 | RANGANATH, RAJESH | reporter.nih.gov |
| A K63-Ubiquitination Dependent Necroptosis Signaling Network in the Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,943,750 | January 8, 2021 | December 31, 2026 | LIU, QINGHANG | reporter.nih.gov |
| miR-615, AKT/eNOS signaling, and angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,942,564 | May 15, 2020 | April 30, 2024 | FEINBERG, MARK W | reporter.nih.gov |
| Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,939,355 | July 1, 2020 | July 2, 2024 | DEBOSCH, BRIAN JESSE | reporter.nih.gov |
| A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,934,984 | December 1, 2020 | November 30, 2025 | MIYAZAKI, MAKOTO | reporter.nih.gov |
| Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,934,572 | May 1, 2022 | April 30, 2026 | MILNER, THOMAS E | reporter.nih.gov |
| Leveraging the mitochondrial regulator MIRO1 to prevent neointimal hyperplasia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,926,265 | December 1, 2021 | May 31, 2025 | GRUMBACH, ISABELLA MARIA | reporter.nih.gov |
| Circadian Rhythm as a Therapeutic Target for Perioperative Cardioprotection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,925,827 | May 11, 2023 | April 30, 2027 | ELTZSCHIG, HOLGER K. | reporter.nih.gov |
| Ischemia/Reperfusion injury and Myocardial edema | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,915,267 | July 1, 2023 | June 30, 2027 | SIMONS, MICHAEL | reporter.nih.gov |
| Engineering a cross-linked cellular network for cardiac repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,912,343 | September 1, 2022 | August 31, 2026 | NGUYEN, JULIANE | reporter.nih.gov |
| Molecular Drivers of Atherosclerosis in Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,910,575 | September 18, 2024 | June 30, 2027 | ONENGUT, SUNA | reporter.nih.gov |
| Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,907,161 | May 1, 2023 | April 30, 2027 | BAUER, ROBERT CLAYTON | reporter.nih.gov |
| Preclinical imaging of immune responses to chronic stress | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,905,800 | July 1, 2023 | June 30, 2028 | VAN LEENT, MANDY MARIA THERESIA | reporter.nih.gov |
| Engineered BacNav and BacCav for Improved Excitability and Contraction | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $1,900,343 | May 1, 2022 | January 31, 2027 | BURSAC, NENAD | reporter.nih.gov |
| Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,895,277 | April 1, 2020 | March 31, 2025 | ROSENGART, TODD K | reporter.nih.gov |
| Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,891,065 | March 15, 2008 | February 28, 2026 | WOO, Y JOSEPH | reporter.nih.gov |
| Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT) | NIH | National Institute on Aging | 2021 to 2023 | $1,890,893 | July 15, 2019 | April 30, 2025 | DODSON, JOHN A | reporter.nih.gov |
| Clinical and Molecular Epidemiology of High Risk Coronary Plaque | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,889,754 | August 1, 2019 | July 31, 2024 | SHAH, SVATI H. | reporter.nih.gov |
| Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,880,847 | June 1, 2023 | May 31, 2028 | BADRAN, MOHAMMAD | reporter.nih.gov |
| Genetic Prediction for Treatment Resistance in Kawasaki Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,880,732 | December 15, 2018 | November 30, 2023 | PORTMAN, MICHAEL A | reporter.nih.gov |
| Genetics of Cardiovascular Disease in Chronic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,872,629 | May 1, 2022 | April 30, 2026 | FRANCESCHINI, NORA | reporter.nih.gov |
| Neural Inflammation and Exercise Pressor Reflex in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,872,119 | August 16, 2023 | June 30, 2027 | WANG, HANJUN | reporter.nih.gov |
| The transcriptional control of vascular calcification in disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,865,635 | March 15, 2023 | February 28, 2027 | MIYAZAKI, MAKOTO | reporter.nih.gov |
| Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,862,346 | March 1, 2022 | February 28, 2026 | CHAUDHRY, SARWAT I | reporter.nih.gov |
| Vascular calcification and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,860,950 | January 1, 2021 | December 31, 2026 | SAVINOVA, OLGA V. | reporter.nih.gov |
| AI-based Cardiac CT | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,859,635 | May 1, 2023 | February 28, 2028 | YU, HENGYONG | reporter.nih.gov |
| 1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD) | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,858,859 | September 25, 2024 | August 31, 2025 | PATEL, MANESH R | reporter.nih.gov |
| Prevent Unnecessary Carotid Intervention and Stroke using Noninvasive Transcutaneous Ultrasound Thermal Strain Imaging (US-TSI) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,858,255 | June 15, 2020 | May 31, 2025 | KIM, KANG | reporter.nih.gov |
| Metabolic and Transcriptional Reprogramming of Cardiac Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,853,015 | April 1, 2021 | March 31, 2025 | MURRY, CHARLES E | reporter.nih.gov |
| 1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD) | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,841,946 | September 25, 2024 | August 31, 2029 | PATEL, MANESH R | reporter.nih.gov |
| Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,838,919 | September 1, 2020 | August 31, 2024 | NATARAJAN, PRADEEP | reporter.nih.gov |
| Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular Reactivity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,835,874 | August 1, 1992 | March 31, 2026 | SELLKE, FRANK W | reporter.nih.gov |
| Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,835,045 | March 1, 2016 | April 30, 2025 | STAFFORD, JOHN MICHAEL | reporter.nih.gov |
| Metabolic regulation of myocardial perfusion in the aging heart | NIH | National Institute on Aging | 2025 | $1,828,658 | September 15, 2024 | August 31, 2029 | HILL, BRADFORD GUY | reporter.nih.gov |
| Systems Genetics of Vascular Smooth Muscle Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,820,349 | December 15, 2022 | June 30, 2025 | CIVELEK, METE | reporter.nih.gov |
| Macrophage functional dynamics in adult heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,817,380 | April 1, 2023 | March 31, 2027 | LIU, JIANDONG | reporter.nih.gov |
| Using Genetics to Inform Mechanism of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,814,970 | February 1, 2017 | June 30, 2022 | WILLER, CRISTEN J | reporter.nih.gov |
| The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,813,049 | April 1, 2023 | March 31, 2027 | TRASK, AARON J | reporter.nih.gov |
| The role of microglia Nek6 in myocardial infarction-induced cognitive impairment | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,805,517 | July 1, 2020 | June 30, 2025 | DUTTA, PARTHA | reporter.nih.gov |
| Sensing Vulnerable Plaque in vivo by an All-optical Intravascular Ultrasound and Photoacoustic Catheter | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,804,444 | August 1, 2015 | August 31, 2025 | CHENG, JI-XIN | reporter.nih.gov |
| Cardiac Pathophysiology of Proteasome Phosphoregulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,800,966 | September 1, 2020 | April 30, 2029 | WANG, XUEJUN | reporter.nih.gov |
| Expansion of Percutaneous Coronary Intervention in Outpatient and Inpatient Settings: Quantifying the Differential Impact Between Disadvantaged and Non-Disadvantaged Communities | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,799,520 | July 1, 2016 | June 30, 2027 | HSIA, RENEE YUEN-JAN | reporter.nih.gov |
| Opportunistic Atherosclerotic Cardiovascular Disease Risk Estimation at Abdominal CTs with Robust and Unbiased Deep Learning | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,796,488 | September 1, 2023 | May 31, 2028 | CHAUDHARI, AKSHAY | reporter.nih.gov |
| Anti-Inflammatory Roles and Macrophage Metabolism of Lactate and Ketones during Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,789,958 | August 11, 2023 | July 31, 2028 | MOUTON, ALAN J | reporter.nih.gov |
| FAT cadherins and vascular remodeling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,780,272 | December 15, 2022 | November 30, 2026 | SIBINGA, NICHOLAS E | reporter.nih.gov |
| Hippo and Wnt Signaling in Cardiac Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,766,058 | January 15, 2016 | December 31, 2024 | MARTIN, JAMES F | reporter.nih.gov |
| IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,760,696 | August 15, 2018 | January 31, 2023 | RUIZ-LOZANO, PILAR | reporter.nih.gov |
| Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,760,000 | March 1, 2022 | February 28, 2027 | WANG, ZHAO | reporter.nih.gov |
| The role of pericytes in scar formation following stroke and myocardial infarction | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,758,240 | March 1, 2020 | February 28, 2025 | CARMICHAEL, STANLEY THOMAS | reporter.nih.gov |
| Role of ROCK isoform-mediated actin cytoskeleton modification in the pathogenesis of heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,755,090 | January 15, 2021 | December 31, 2025 | WEI, LEI | reporter.nih.gov |
| Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,751,600 | December 25, 2021 | November 30, 2026 | XIE, LAI-HUA | reporter.nih.gov |
| MMP responsive polymeric materials for treating acute myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,747,774 | September 1, 2017 | June 30, 2027 | CHRISTMAN, KAREN L | reporter.nih.gov |
| Myeloid cells are critical in inflammatory heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,747,535 | February 1, 2014 | June 30, 2025 | CIHAKOVA, DANIELA | reporter.nih.gov |
| Cardiac protective mechanisms of melanocortin system activation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,747,424 | January 9, 2023 | December 31, 2026 | SILVA, ALEXANDRE ALVES DA | reporter.nih.gov |
| Mechanisms of Cell-Based Heart Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,742,404 | April 1, 2019 | March 31, 2025 | SNIADECKI, NATHAN JOHN | reporter.nih.gov |
| Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,740,413 | April 10, 2020 | March 31, 2026 | MENDELOWITZ, DAVID | reporter.nih.gov |
| Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,736,459 | July 15, 2024 | June 30, 2028 | WEI, WEI-QI | reporter.nih.gov |
| Investigation of Partial Electrical Nerve Block for Autonomic Regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,729,684 | January 6, 2020 | December 31, 2025 | VRABEC, TINA LOUISE | reporter.nih.gov |
| Cardiac afferents and renal function in heart failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,714,995 | December 18, 2015 | December 31, 2024 | ZUCKER, IRVING H | reporter.nih.gov |
| HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,709,530 | September 1, 2018 | February 28, 2025 | SHULER, MICHAEL L | reporter.nih.gov |
| The Effects of Bundled Payment on Acute Cardiovascular Outcomes Among Older Adults | NIH | National Institute on Aging | 2023 to 2025 | $1,707,931 | September 1, 2015 | March 31, 2027 | RYAN, ANDREW M | reporter.nih.gov |
| Innovative Voltage-Activated Ultrasound Imaging Agent for Selective Myocardial Enhancement | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,707,452 | July 1, 2021 | June 30, 2024 | CIMORELLI, MICHAEL | reporter.nih.gov |
| Administrative Supplement to 7R01HL148060-03 Titled: Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,697,970 | April 15, 2020 | January 31, 2024 | HARDING, PAMELA | reporter.nih.gov |
| Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,696,127 | September 1, 2023 | June 30, 2027 | BAE, YONGHO | reporter.nih.gov |
| A dialogue between neutrophils and monocytes for effective resolution of inflammation following acute myocardial injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,695,891 | July 1, 2022 | June 30, 2027 | NAGAREDDY, PRABHAKARA REDDY | reporter.nih.gov |
| Restoration and Function of S-Nitrosothiol in Stored Blood | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,690,342 | December 1, 2016 | January 31, 2028 | STAMLER, JONATHAN S. | reporter.nih.gov |
| Dysregulations in Polyamine Metabolism During Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,688,538 | April 1, 2023 | March 31, 2028 | YURDAGUL, ARIF | reporter.nih.gov |
| STK25 phosphorylates PRKAR1A to regulate PKA signaling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,687,751 | August 1, 2023 | June 30, 2028 | FINE, BARRY M. | reporter.nih.gov |
| Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in ACS Survivors | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $1,684,273 | September 5, 2022 | August 31, 2026 | YEH, GLORIA Y | reporter.nih.gov |
| Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,682,636 | January 15, 2019 | December 31, 2023 | FAYAD, ZAHI A. | reporter.nih.gov |
| Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,680,897 | December 10, 2019 | November 30, 2025 | KISHORE, RAJ | reporter.nih.gov |
| Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,680,264 | July 1, 2023 | June 30, 2027 | BANSAL, SHYAM SUNDER | reporter.nih.gov |
| Acid, Succinate and Glyoxal Metabolism in Ischemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,675,811 | July 1, 2003 | September 30, 2026 | BROOKES, PAUL S | reporter.nih.gov |
| Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,670,000 | July 1, 2021 | June 30, 2025 | NOVAL RIVAS, MAGALI | reporter.nih.gov |
| The role of GATA3-positive macrophages in cardiovascular pathologies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,670,000 | July 1, 2022 | June 30, 2026 | SHAH, PREDIMAN KRISHAN | reporter.nih.gov |
| Mechanisms of sex-biased risk and resiliency in aneurysm and dissection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,670,000 | September 16, 2022 | August 31, 2026 | PARKER, SARAH J | reporter.nih.gov |
| Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,666,593 | August 9, 2019 | July 31, 2025 | ZANNI, MARKELLA V. | reporter.nih.gov |
| The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,661,047 | December 1, 2021 | November 30, 2026 | FU, XING | reporter.nih.gov |
| Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,658,695 | April 22, 2020 | September 22, 2023 | MOHAMED, TAMER M A | reporter.nih.gov |
| A mixed methods study to identify and refine implementation strategies to increase use of cardiac rehabilitation for patients with heart failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,657,051 | May 25, 2021 | February 28, 2025 | LAGU, TARA C | reporter.nih.gov |
| SUMO2-p66shc axis in vascular endothelial dysfunction and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,651,874 | April 1, 2020 | March 31, 2026 | KUMAR, SANTOSH | reporter.nih.gov |
| Molecular Regulation of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,645,376 | February 1, 2019 | January 31, 2025 | CHEN, HONG | reporter.nih.gov |
| PFAS accelerate atherosclerosis through modulation of bile acid metabolism | NIH | National Institute of Environmental Health Sciences | 2023 | $1,644,161 | September 19, 2023 | August 31, 2026 | PETRIELLO, MICHAEL CURTIS | reporter.nih.gov |
| Targeting cardiac fibroblast-myocyte cross talk to enhance heart function after cardiac injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,638,000 | September 2, 2020 | August 31, 2025 | DEB, ARJUN | reporter.nih.gov |
| Cardiac AAV gene delivery for clinical translation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,637,150 | April 2, 2024 | January 31, 2029 | ISHIKAWA, KIYOTAKE | reporter.nih.gov |
| Impact of the COVID-19 pandemic, SARS-CoV-2 infection and social determinants of health on pregnancy complications, birth outcomes and post-pregnancy maternal cardiovascular and mortality outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,632,961 | April 1, 2022 | March 31, 2026 | MALEK, ANGELA M | reporter.nih.gov |
| Dysregulated Adiponectin Transmembrane Signaling in Diabetic CoronaryVascular Injury and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,628,214 | February 1, 2022 | January 31, 2027 | WANG, YAJING | reporter.nih.gov |
| Circadian regulation of vascular aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,628,142 | January 18, 2019 | December 31, 2024 | CHEN, YABING | reporter.nih.gov |
| Comparing a Novel Telehealth-enabled Hybrid Cardiac Rehabilitation Program to Clinic-based Cardiac Rehabilitation for Improving Patient Engagement and Functional Outcomes after ACS | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,628,101 | September 20, 2024 | May 31, 2029 | DURAN, ANDREA T | reporter.nih.gov |
| The Role of Food Sensitization in Cardiovascular Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,626,865 | August 13, 2024 | July 31, 2029 | KEET, CORINNE | reporter.nih.gov |
| TNFR1 Expressing Exosomes are Critical Mediators of Pathological Immune Activation in the Spleen post-Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,624,306 | September 7, 2021 | July 31, 2027 | BANSAL, SHYAM SUNDER | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,620,596 | September 6, 2021 | September 7, 2021 | SHAW, LESLEE J | reporter.nih.gov |
| Understanding the role of mitochondrial dysfunction in cardiac arrhythmias using a novel 3D panoramic optical mapping system | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,620,000 | April 1, 2020 | March 31, 2025 | WAN, ELAINE Y | reporter.nih.gov |
| Novel Neural Mechanisms underlying Lung-Heart Pathological Crosstalk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,617,138 | April 1, 2020 | March 31, 2025 | WANG, HANJUN | reporter.nih.gov |
| DYRK1a as a therapeutic target to treat myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,615,000 | August 15, 2021 | July 31, 2025 | WOLF, MATTHEW J | reporter.nih.gov |
| Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,609,612 | July 8, 2024 | June 30, 2028 | CHEN, HONG | reporter.nih.gov |
| Clonal Hematopoiesis in Healthy Individuals from Families with Early OnsetCoronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,606,957 | May 1, 2019 | April 30, 2025 | BECKER, LEWIS C | reporter.nih.gov |
| Simple and Effective Laceration of Potentially-calcified Leaflets as an Adjunct to Transcatheter Valve Replacement | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,606,814 | January 20, 2024 | December 31, 2027 | DUPONT, PIERRE E | reporter.nih.gov |
| NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,604,907 | April 1, 2023 | March 31, 2027 | SILVERSTEIN, ROY L | reporter.nih.gov |
| Effect of CTHRC1 on endothelial cell survival after acute ischemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,603,728 | December 20, 2019 | November 30, 2025 | LINDNER, VOLKHARD | reporter.nih.gov |
| Unique value of real-time shear stress to enhance coronary disease management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,603,334 | January 1, 2018 | December 31, 2024 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Enhancing Autophagy and Mitochondrial Biogenesis to Mitigate Cardiac Reperfusion Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,600,586 | July 1, 2020 | June 30, 2026 | XIE, MIN | reporter.nih.gov |
| CARDIA Year 35 Brain MRI Renewal | NIH | National Institute on Aging | 2021 to 2022 | $1,599,247 | September 15, 2019 | May 31, 2025 | BRYAN, R N | reporter.nih.gov |
| Cardiac delivery of RNA to treat contractile disorder | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,590,483 | July 1, 2024 | April 30, 2028 | MARGULIES, KENNETH BER | reporter.nih.gov |
| Mechanisms of myocardial regeneration mediated by Nkx2.5 in zebrafish | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,578,254 | April 1, 2023 | March 31, 2028 | TARGOFF, KIMARA L | reporter.nih.gov |
| q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,576,624 | February 18, 2014 | February 28, 2025 | DUNCAN, JAMES S | reporter.nih.gov |
| Lipidation and Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,575,000 | April 21, 2021 | March 31, 2026 | SEMENKOVICH, CLAY F. | reporter.nih.gov |
| Targeting Adiponectin for Cardioprotection in the Ischemic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,574,916 | May 1, 2010 | November 30, 2025 | MA, XIN-LIANG | reporter.nih.gov |
| Molecular control of ischemia-induced tissue fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,573,551 | July 1, 2020 | June 30, 2025 | YU, JUN | reporter.nih.gov |
| Macrophage Inflammarafts and Mitochondrial Dysfunction in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,571,556 | February 1, 2024 | January 31, 2028 | MILLER, YURY | reporter.nih.gov |
| An Information tecHnology approach to implEmenting depression treAtment in caRdiac patienTs: [iHeart Trial] | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,570,899 | April 1, 2018 | March 31, 2025 | MOISE, NATHALIE | reporter.nih.gov |
| Modeling of cell-specific LRP1 signaling in acute myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,568,092 | August 12, 2024 | April 30, 2028 | SAUCERMAN, JEFFREY J. | reporter.nih.gov |
| Risk Factors for CVD in Women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,562,202 | December 1, 1984 | May 31, 2024 | MANSON, JOANN ELISABETH | reporter.nih.gov |
| Printed Electronic Biosensors for Point-of-Care Testing of Cardiovascular Biomarkers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,558,958 | April 15, 2019 | March 31, 2025 | FRANKLIN, AARON | reporter.nih.gov |
| The methyltransferase Smyd1 regulates cardiac physiology | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,558,425 | July 15, 2022 | June 30, 2027 | FRANKLIN, SARAH | reporter.nih.gov |
| Air Pollution, Coronary Events and Atherosclerotic Progression in a Susceptible Population | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,558,412 | July 21, 2021 | April 30, 2027 | WANG, MENG | reporter.nih.gov |
| Immune mechanisms of influenzaâÂÂinduced exacerbation of atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,558,220 | August 15, 2020 | July 31, 2025 | GOPAL, RADHA | reporter.nih.gov |
| Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,556,464 | April 1, 2021 | March 31, 2026 | PRABHU, SUMANTH D | reporter.nih.gov |
| The Deubiquitinase CYLD Controls Multiple Cell Death Pathways in the Heart | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,555,000 | April 1, 2022 | March 31, 2027 | LIU, QINGHANG | reporter.nih.gov |
| Novel sphingolipid metabolites in myocardial ischemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,552,500 | July 7, 2020 | June 30, 2025 | COWART, LAUREN ASHLEY | reporter.nih.gov |
| ApoE receptor-2 in vascular disease progression and regression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,551,783 | April 1, 2019 | March 31, 2024 | HUI, DAVID YIU-KWAN | reporter.nih.gov |
| Patient-Specific Simulations to Guide Coronary Bifurcation Stenting | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,549,766 | April 15, 2019 | January 17, 2023 | CHATZIZISIS, IOANNIS S | reporter.nih.gov |
| IDOL and dyslipidemia in cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,547,876 | September 1, 2019 | July 31, 2024 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Genetic modulation of inflammation following myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,547,467 | September 1, 2024 | June 30, 2029 | GUMINA, RICHARD J | reporter.nih.gov |
| Surgical Microneedle Patch Delivery of CMMP for Heart Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,542,902 | April 20, 2020 | June 30, 2023 | CHENG, KE | reporter.nih.gov |
| Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,540,142 | January 1, 2024 | December 31, 2028 | CHEN, WEI | reporter.nih.gov |
| Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,538,825 | March 17, 2020 | February 28, 2025 | JAFFER, FAROUC AMIN | reporter.nih.gov |
| Epigenomic signaling and heart failure. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,538,638 | December 6, 2019 | November 30, 2025 | CHANG, JIANG | reporter.nih.gov |
| IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,537,348 | February 1, 2019 | January 31, 2024 | OWENS, GARY K | reporter.nih.gov |
| Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial Infarctions | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,535,864 | March 5, 2020 | February 28, 2025 | DHARMAKUMAR, ROHAN | reporter.nih.gov |
| Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,529,131 | May 25, 2024 | February 28, 2028 | FERRAN, CHRISTIANE | reporter.nih.gov |
| Measurement and Reduction of Low-Value Cardiovascular Care | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,526,692 | April 1, 2024 | February 28, 2029 | KINI, VINAY | reporter.nih.gov |
| Effects of SGLT2 Inhibition on Coronary Flow Reserve and Other Key Indices Relevant to Type 2 Myocardial Infarction Risk among Women with HIV | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,524,171 | September 1, 2024 | August 31, 2029 | ZANNI, MARKELLA V. | reporter.nih.gov |
| LONGITUDINAL ASSOCIATION OF POST-INFARCT LIPOMATOUS METAPLASIA AND MALIGNANT ARRHYTHMIA | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,524,018 | August 1, 2024 | July 31, 2029 | NAZARIAN, SAMAN | reporter.nih.gov |
| Role of collagen heterogeneity in remodeling of acute and chronic heart scars | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,521,000 | July 1, 2020 | June 30, 2025 | DEB, ARJUN | reporter.nih.gov |
| Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,520,640 | January 1, 2010 | November 30, 2025 | SHEU, SHEY-SHING | reporter.nih.gov |
| Role of the mitochondrial LonP1 in myocardial ischemia and reperfusion injury protection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,520,000 | June 10, 2022 | May 31, 2027 | SUNDARARAJAN, VENKATESH | reporter.nih.gov |
| Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,518,930 | April 1, 2021 | March 31, 2025 | CHENG, KE | reporter.nih.gov |
| Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,516,842 | July 1, 2023 | June 30, 2027 | TANG, YAO LIANG | reporter.nih.gov |
| Preventing Myocardial Events of Aging: A PREVENTABLE Ancillary Study | NIH | National Institute on Aging | 2024 to 2025 | $1,512,879 | February 1, 2024 | November 30, 2028 | GOYAL, PARAG | reporter.nih.gov |
| Aptamer-functionalized cardiac patches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,510,900 | August 1, 2015 | May 31, 2025 | WANG, YONG | reporter.nih.gov |
| Brain-immune crosstalk in myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,510,152 | May 1, 2023 | April 30, 2028 | POLLER, WOLFRAM CHRISTIAN | reporter.nih.gov |
| T Lymphopenia in Ischemic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,507,767 | July 1, 2022 | June 30, 2027 | MA, YONGGANG | reporter.nih.gov |
| RISK FACTORS FOR CVD IN WOMEN | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,506,545 | December 1, 1984 | August 31, 2028 | QI, LU | reporter.nih.gov |
| Comparing hospitalization rates, outcomes, and treatment intensity for elderly patients across OECD countries | NIH | National Institute on Aging | 2022 to 2024 | $1,502,864 | July 1, 2019 | March 31, 2026 | LANDON, BRUCE E. | reporter.nih.gov |
| Mechanisms that Govern and Promote Cardiovascular Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,502,316 | July 10, 2019 | June 30, 2024 | GARRY, DANIEL J. | reporter.nih.gov |
| Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,502,009 | September 1, 2021 | August 2, 2022 | SHUFELT, CHRISANDRA LEE | reporter.nih.gov |
| The role of Pitx2 in heart injury and regeneration. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,495,000 | April 1, 2020 | March 31, 2026 | TAO, GE | reporter.nih.gov |
| Post-Transcriptional Regulation of Gene Expression by Ribosome-Binding Protein 1 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,494,652 | May 10, 2024 | April 30, 2029 | DOROUDGAR, SHIRIN | reporter.nih.gov |
| Collagen-derived peptides to target inflammation in myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,489,669 | December 15, 2021 | November 30, 2026 | DE CASTRO BRAZ, LISANDRA E | reporter.nih.gov |
| Noninvasive Testing of Coronary Microvascular Reactivity Using High-resolution Free-breathing MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,489,262 | July 15, 2020 | November 1, 2024 | SHARIF, BEHZAD | reporter.nih.gov |
| SNRK in ischemic vascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,489,006 | April 1, 2018 | April 30, 2023 | XIE, ZHONGLIN | reporter.nih.gov |
| Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004. | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,488,899 | April 1, 2025 | December 31, 2026 | YOUNG, LINDON H | reporter.nih.gov |
| Stellate Ganglia Nrf2 Signaling and Enhanced Cardiac Sympathetic Tone in Chronic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,483,024 | September 1, 2024 | August 31, 2028 | WANG, HANJUN | reporter.nih.gov |
| Predictive and systems modeling of exosome cargo | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,483,018 | January 1, 2019 | December 31, 2023 | DAVIS, MICHAEL E | reporter.nih.gov |
| Impact of L. plantarum 299v Supplementation on Endothelial Function and Systemic Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,482,252 | March 22, 2019 | January 31, 2025 | WIDLANSKY, MICHAEL E | reporter.nih.gov |
| Biphasic Regulation of Endothelial Transdifferentiation by Alcohol and Its Impact on Vascular Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,481,378 | September 20, 2023 | August 31, 2028 | REDMOND, EILEEN M. | reporter.nih.gov |
| Inhalable stem cell exosome therapy for cardiac injury | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,478,554 | June 4, 2024 | May 31, 2028 | CHENG, KE | reporter.nih.gov |
| Novel Gene Therapy For Chronic Ischemic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,477,192 | January 16, 2024 | December 31, 2027 | SHAW, ROBIN M | reporter.nih.gov |
| Novel methodologies to improve coronary artery disease diagnostics with dynamic PET | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,476,019 | July 1, 2024 | June 30, 2029 | TANG, JING | reporter.nih.gov |
| The Effects of Changing Health Care Markets on Cardiovascular and Cerebrovascular Care and Outcomes | NIH | National Institute on Aging | 2024 to 2025 | $1,474,883 | September 15, 2024 | August 31, 2029 | ZACHRISON, KORILYN SAUSER | reporter.nih.gov |
| Targeted Anti-IL-1β Platelet Mimetics for Cardiac Detoxification and Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,472,172 | April 1, 2015 | March 31, 2024 | CHENG, KE | reporter.nih.gov |
| Biomimetic nanomaterials for the immunomodulation of the cardiosplenic axis post-myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,471,030 | July 1, 2024 | June 30, 2028 | MENICK, DONALD R. | reporter.nih.gov |
| Adenine metabolism in cardiac repair | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,470,265 | July 25, 2024 | April 30, 2028 | DEB, ARJUN | reporter.nih.gov |
| Per- and polyfluoroalkyl substances, apolipoproteins, and risk of coronary heart disease | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,468,436 | April 16, 2024 | January 31, 2029 | SUN, QI | reporter.nih.gov |
| CARDIA CHICAGO FC - TASK AREA A PERIOD OF PERFORMANCE OPY 1: 07/01/2019 - 06/30/2020 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,466,802 | July 1, 2018 | June 30, 2023 | LLOYD-JONES, DONALD | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston, MA | 53 | $86.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 49 | $52.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 28 | $50.7 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 11 | $46.3 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 25 | $45.7 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 30 | $44.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 29 | $42.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 30 | $41.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 18 | $39.3 million | 0 | $0 |
| Duke University | Durham, NC | 25 | $38.7 million | 0 | $0 |
| Yale University | New Haven, CT | 27 | $34.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 24 | $31.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 29 | $31.3 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 19 | $30.5 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 27 | $30.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 23 | $30.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 17 | $30 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 23 | $29.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 24 | $29 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 22 | $28.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 14 | $24.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 6 | $24.3 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 20 | $23.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 15 | $23.8 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 15 | $22.6 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 20 | $22 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 17 | $21.1 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 16 | $20.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 15 | $20.3 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 16 | $20 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 16 | $19.5 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 14 | $19.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 10 | $19 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 19 | $19 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 12 | $17.6 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 7 | $15.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 13 | $15.4 million | 0 | $0 |
| University of Louisville | Louisville, KY | 17 | $15.3 million | 0 | $0 |
| Augusta University | Augusta, GA | 7 | $15.3 million | 0 | $0 |
| Ohio State University | Columbus, OH | 16 | $13.4 million | 0 | $0 |
| Chapman University | Orange, CA | 1 | $12.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 10 | $12.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 10 | $12.1 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 9 | $11.9 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 14 | $11.2 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 9 | $10.8 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 7 | $10.8 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 6 | $10.7 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 10 | $10.7 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 16 | $10.7 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 9 | $10.5 million | 0 | $0 |
| Cardiac RSK3 Inhibitors, LLC | Los Altos, CA | 3 | $10.2 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 8 | $9.3 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 8 | $9.2 million | 0 | $0 |
| University of Rochester | Rochester, NY | 11 | $8.8 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 3 | $8.7 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 11 | $8.6 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 7 | $8.6 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 9 | $8.4 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 8 | $8.2 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 8 | $8 million | 0 | $0 |
| Brown University | Providence, RI | 7 | $7.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 4 | $7.8 million | 0 | $0 |
| University of South Florida | Tampa, FL | 9 | $7.3 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 5 | $7.3 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 5 | $7.2 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 3 | $7.1 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 4 | $6.9 million | 0 | $0 |
| Columbia University | New York, NY | 5 | $6.8 million | 0 | $0 |
| Tougaloo College | Tougaloo, MS | 2 | $6.6 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 7 | $6.4 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 5 | $6.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 8 | $6.3 million | 0 | $0 |
| George Washington University | Washington, DC | 4 | $6.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 4 | $6.2 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 6 | $6.1 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 7 | $6.1 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 2 | $6 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 6 | $5.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 3 | $5.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 6 | $5.3 million | 0 | $0 |
| Jackson State University | Jackson, MS | 2 | $5.1 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 4 | $4.9 million | 0 | $0 |
| Apt Therapeutics, Inc. | Naperville, IL | 1 | $4.7 million | 0 | $0 |
| Clemson University | Clemson, SC | 6 | $4.6 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $4.4 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 5 | $4.3 million | 0 | $0 |
| Louisiana State Univ HSC Shreveport | Shreveport, LA | 6 | $4.3 million | 0 | $0 |
| General Electric Global Research CTR | Niskayuna, NY | 2 | $4.2 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 4 | $4.1 million | 0 | $0 |
| Northwestern University | Chicago, IL | 1 | $4.1 million | 0 | $0 |
| Northeast Ohio Medical University | Rootstown, OH | 5 | $4 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 4 | $4 million | 0 | $0 |
| Wayne State University | Detroit, MI | 3 | $3.8 million | 0 | $0 |
| Crossliner INC | Kalamazoo, MI | 1 | $3.8 million | 0 | $0 |
| Mainehealth | Portland, ME | 3 | $3.8 million | 0 | $0 |
| Texas Tech University Health Scis Center | Lubbock, TX | 2 | $3.5 million | 0 | $0 |
| Mount Sinai Medical Center (miami Beach) | Miami Beach, FL | 2 | $3.5 million | 0 | $0 |
| Texas Heart Institute | Houston, TX | 4 | $3.4 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 4 | $3.4 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 599 | $366,832,874 | 0 | $0 |
| 2024 | 614 | $346,539,015 | 0 | $0 |
| 2023 | 648 | $383,389,059 | 0 | $0 |
| 2022 | 685 | $363,482,882 | 0 | $0 |
| 2021 | 675 | $349,420,344 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 16 awards here | |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 5 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.837 | December 4, 2026 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.837 | January 7, 2027 | $375,000 | Same assistance listing 93.837 as 1,147 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.837 | January 7, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.837 | February 3, 2027 | $1.5 million | Same assistance listing 93.837 as 1,147 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.837 | February 3, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | PAR-27-125 | NIH | 93.837 | February 16, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | RFA-DK-27-108 | NIH | 93.837 | March 10, 2027 | $500,000 | Same assistance listing 93.837 as 1,147 awards here |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | PAR-25-032 | NIH | 93.837 | March 16, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.837 | April 9, 2027 | $200,000 | Same assistance listing 93.837 as 1,147 awards here |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | RFA-HL-26-002 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | RFA-HL-26-003 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 1,147 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.